CRP and cancer: A high score in the modified Glasgow prognostic score (mGPS) is associated with poor prognosis in advanced cancer and utilises increased serum fibrinogen and CRP and decreased serum albumin levels, demonstrating the centrality of systemic inflammation [6,8].